 | | PRD_000724 | | Name: | PYOVERDIN 18-1 Fe Complex | | Formula: | C57 H84 Fe N17 O24 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000725 | | Name: | PYOVERDIN R Fe Complex | | Formula: | C48 H64 Fe N15 O21 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000726 | | Name: | PYOVERDIN 13525 Fe Complex | | Formula: | C49 H71 Fe N14 O19 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000728 | | Name: | Synthetic PYOVERDINE Fe Complex | | Formula: | C56 H81 Fe N17 O24 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000752 | | Name: | CIRCULIN A | | Formula: | C134 H211 N38 O38 S6 | | Definition date: | 2020-08-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000758 | | Name: | THIOPEPTIDE THIOSTREPTON REDUCED AT N-CA BOND OF RESIDUE 14 | | Formula: | C72 H86 N19 O18 S5 | | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES, ONE THIOZOLINE,
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 14 WAS CHEMICALLY MODIFIED TO
HAVE A SINGLE BOND N-CA. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000759 | | Name: | THIOPEPTIDE THIOSTREPTON WITH EPIMER FORM OF RESIDUE 9 | | Formula: | C69 H81 N18 O17 S5 | | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED
FROM D-CYS TO L-CYS AND RESIDUE 17 (HET DHA)
WAS DELETED. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000760 | | Name: | THIOPEPTIDE THIOSTREPTON OXIDIZED AT CA-CB BOND OF RESIDUE 9 | | Formula: | C69 H79 N18 O17 S5 | | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE LINKED TO MAIN-CHAIN
RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED: THE
CA-CB BOND WAS OXIDIZED FROM SINGLE TO DOUBLE.
RESIDUE 17 (HET DHA) WAS DELETED. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000764 | | Name: | CYCLOSPORIN D, 5,7 mutation | | Formula: | C64 H117 N11 O12 S | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED IN DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL).
THE CYCLOSPORIN D MOLECULE WAS MODIFIED AT
POSITIONS 5 AND 7 TO BE
(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE AND
(2-S-METHYL)-SARCOSINE, RESPECTIVELY. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000765 | | Name: | CYCLOSPORIN A, 5 mutation | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN WAS MODIFIED AT POSITION 5 TO BE
4-[(E)-2-BUTENYL]-4,4,N-TRIMETHYL-L-THREONINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000766 | | Name: | CYCLOSPORIN A, 6 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 6 TO BE 2-AMINO-5-HYDROXYPENTANOIC ACID | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000767 | | Name: | CYCLOSPORIN A, 7 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A WAS MODIFIED AT POSITION 7
TO BE N-METHYL-D-SERINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000768 | | Name: | CYCLOSPORIN A, 8 mutation | | Formula: | C62 H111 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 8 TO BE N-METHYL-ISOLEUCINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_002426 | | Name: | Corramycin | | Formula: | C51 H81 N11 O21 | | Definition date: | 2023-08-16 | | Last modified: | 2023-08-16 |
|
 | | PRD_002431 | | Name: | Cyclic tetraadenosine monophosphate (cA4) | | Formula: | C40 H48 N20 O24 P4 | | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-03 |
|
 | | PRD_002346 | | Name: | Inhibitor ARC-3126 | | Formula: | C58 H108 Br N31 O9 S | | Definition date: | 2021-08-04 | | Last modified: | 2023-06-11 |
|
 | | PRD_002515 | | Name: | all-D Helicon Polypeptide FP40918 | | Formula: | C84 H115 N22 O26 S2 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002324 | | Name: | [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | | Formula: | C62 H111 N11 O13 | | Definition date: | 2018-09-12 | | Last modified: | 2018-09-12 |
|
 | | PRD_001132 | | Name: | CYCLOSPORIN D | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | | Definition date: | 2013-07-02 | | Last modified: | 2017-05-04 |
|
 | | PRD_002186 | | Name: | 6-ammonio-N-[3-(9H-fluoren-9-yl)propanoyl]-L-norleucyl-6-ammonio-L-norleucyl-L-alpha-glutamyl-L-threonyl-L-alpha-glutamyl-L-valine | | Formula: | C47 H70 N8 O13 | | Definition date: | 2016-08-17 | | Last modified: | 2016-08-17 |
|
 | | PRD_002101 | | Name: | N-[(6R,9S,10R,13S,15aR,22S,24aR)-22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-18-(morpholin-4-ylmethyl)-5,8,12,15,21,24-hexaoxo-13-phenyl-1,2,3,5,6,7,8,9,10,13,14,15,15a,16,19,21,22,23,24,24a-icosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxypyridine-2-carboxamide | | Formula: | C50 H63 N9 O10 | | Definition date: | 2014-07-30 | | Last modified: | 2014-07-30 |
|
 | | PRD_001162 | | Name: | Salinamide A | | Formula: | C51 H69 N7 O15 | | Description: | bicyclic depsipeptide salinamide A is a potent anti-inflammatory agent found in the marine bacterium Streptomyces sp. CNB-091. The suggested biosynthesis pathway indicates the peptide core of 1 is probably derived from the hexapeptide Thr-D-Ile-Hpg-MePhe-D-aThr-Ser (Tetrahedron Letters 39 (1998) 3915-3918). | | Definition date: | 2014-05-21 | | Last modified: | 2014-05-21 |
|
 | | PRD_001130 | | Name: | SmBz, cyclosporin A derivative | | Formula: | C70 H118 N11 O14 | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_001070 | | Name: | bacitracin A2 | | Formula: | C66 H106 N17 O16 S | | Definition date: | 2013-08-14 | | Last modified: | 2013-08-14 |
|
 | | PRD_001122 | | Name: | CYCLOSPORIN D | | Formula: | C64 H115 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | | Definition date: | 2013-06-20 | | Last modified: | 2013-06-20 |
|
